Company / Working Capital
PTC Therapeutics, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.3B
FY2025
5-year range
$287.5M / $1.3B
FY2021-FY2025
Trend
+66.4%
vs FY2024
Sector context
#34 of 213
Health Care
What the data says
PTC Therapeutics, Inc.'s working capital of $1.3B is higher than 84% of companies in the Health Care sector (FY2025). Working Capital has increased for 3 consecutive years, from $288M in FY2022 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +6.5%. Top quartile in the Health Care sector.
Improved from $616M to $1.3B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +65.6%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 213This company $1.3B Sector average $934.6M
▼
+39.7% above sector average
Key checks
Key Insights
- PTC Therapeutics, Inc.'s working capital has grown for 3 consecutive years.
- 5-year CAGR of +6.5%, indicating consistent growth.
- In FY2025, working capital increased 66.4% year-over-year.
- Ranks #34 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +66.4% |
| FY2024 | $784.5M | +27.5% |
| FY2023 | $615.5M | +114.1% |
| FY2022 | $287.5M | -35.4% |
| FY2021 | $445.0M | -53.4% |
| FY2020 | $954.4M | +75.6% |
| FY2019 | $543.4M | +252.7% |
| FY2018 | $154.1M | -7.8% |
| FY2017 | $167.0M | -21.1% |
| FY2016 | $211.7M | -31.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026